Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Other industries may be in store for the same reckoning that software has seen, says Tony Kim AI has the whole world economy in its hands, says a BlackRock executive. Artificial intelligence isn't ...

Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround ...

Pfizer is looking to newer products and acquisitions to offset a declining Covid business.

Pfizer sees mixed Q1 signals as growth in key drugs offsets COVID declines. Can pipeline strength and M&A bets support long-term upside?

By Mariam Sunny and Christy Santhosh May 5 (Reuters) - Pfizer said on Tuesday that it expects to return to stronger growth ...

Good day, everyone, and welcome to Pfizer's First Quarter 2026 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Francesca DeMartino, Chief ...

The healthcare giant has been investing heavily in its future growth.

U.S. stocks were higher on Tuesday, while oil prices slid as traders reacted to a number of solid earnings results.

Investors who seek out dividend stocks pay close attention to a company's dividend yield, and high-yield players -- as long ...

Pfizer has underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

Pfizer's declining revenue and questions about its growth have weighed down the stock in recent years. The company, however, has been bolstering its pipeline and has some exciting assets. Its ...